photo walkheader_zpsd5bunpmi.png

Category Archives: Pancreatic Cancer

Clinical Trial Results with Votrient for Advanced Neuroendocrine Tumors

Votrient (pazopanib) is a drug-agent of GlaxoSmithKline that appears to work through targeting angiogenesis and growth pathways, and has been approved for use in renal cell carcinoma and advanced soft tissue sarcoma, and now is under study for use in neuroendocrine tumors. Two other recent targeted agents that have been approved by the U.S. FDA […]

A Setback for ARBs for the Treatment of Pancreatic Cancer?

Again, for more than a decade there have been theoretical discussions about the use of drugs commonly used to treat high blood pressure for use in the treatment of cancer – pancreatic cancer (ductal adenocarcinoma of the pancreas). And having just published a Pancreatica blog entry based on the pre-clinical study and work by Jain […]

ARBs for the Treatment of Pancreatic Cancer?

For more than a decade there have been theoretical discussions about the use of drugs commonly used to treat high blood pressure for use in the treatment of cancer – pancreatic cancer (ductal adenocarcinoma of the pancreas). And there have been some prior preliminary research studies. Now comes a very intriguing and elaborate pre-clinical study […]

Page 21 of 37« First...10...1920212223...30...Last »
Facebook
Facebook